title: CML cytogenetic relapse after cessation of imatinib therapy.
authors.forename: Kensuke
authors.initials: K
authors.lastname: Usuki
authors.forename: Kimiko
authors.initials: K
authors.lastname: Iijima
authors.forename: Seiko
authors.initials: S
authors.lastname: Iki
authors.forename: Akio
authors.initials: A
authors.lastname: Urabe
mesh_terms: D000328:Adult; D001549:Benzamides; D006801:Humans; D000068877:Imatinib Mesylate; D017404:In Situ Hybridization, Fluorescence / Q000379:methods; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000188:drug therapy* / Q000235:genetics; D008297:Male; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012008:Recurrence; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate